What Is GLP-1? A Plain-Language Guide to How These Medications Work
Modern Weight Science Editorial Team
Editorial Team
GLP-1 stands for glucagon-like peptide-1 — a hormone your gut produces naturally after every meal. Understanding what it does, and how medications mimic it, explains almost everything about why these drugs work.
GLP-1 stands for glucagon-like peptide-1 — a hormone your intestines release naturally every time you eat. It was discovered in the 1980s, and for decades it was studied mainly as a diabetes treatment. Over time, researchers realized it had a much broader role in appetite regulation, and the pharmaceutical applications that followed have become some of the most talked-about medications in a generation.
Here is what it does, how the medications work, and what that actually means for your body.
The hormone your gut already makes
When food reaches your small intestine, specialized cells called L-cells release GLP-1 into your bloodstream. This single hormone does several things at once:
- Signals your pancreas to release insulin in response to rising blood sugar — but only when sugar is actually rising, which is what makes it glucose-dependent and safer than older diabetes drugs.
- Suppresses glucagon, a hormone that tells the liver to dump stored sugar into the blood. Less glucagon means less unnecessary blood-sugar elevation.
- Slows gastric emptying — food moves from your stomach into your intestines more slowly, which smooths out the blood sugar spike after a meal and extends the feeling of fullness.
- Acts on the brain — GLP-1 receptors in the hypothalamus and brainstem reduce appetite and the mental preoccupation with food that many people call "food noise."
The problem with your body's own GLP-1 is that it degrades extremely fast — a half-life of roughly two minutes. By the time the meal is digested, the hormone is essentially gone. For a complete look at the hormones that regulate hunger, see Hunger Hormones Explained: Ghrelin, Leptin, Insulin, and GLP-1.
What GLP-1 medications do differently
GLP-1 receptor agonists are molecules engineered to activate the same receptors as natural GLP-1, but resist the enzymes that break it down. Depending on the drug, the half-life stretches from hours to a full week — which is why most of these medications are injected just once weekly.
The result is that the same signals your gut sends briefly after a meal are now present continuously. Your stomach empties more slowly all day. Appetite signals to the brain are persistently dampened. The constant background thinking about food — when to eat next, what to snack on, how to resist a craving — quiets down for many people in a way that feels qualitatively different from willpower-based dieting. This is explored in depth in Why You Feel Hungry All the Time.
GLP-1 vs. dual agonists
Semaglutide (Ozempic, Wegovy) activates the GLP-1 receptor alone. Tirzepatide (Mounjaro, Zepbound) activates both the GLP-1 receptor and a second gut hormone receptor called GIP (glucose-dependent insulinotropic polypeptide). GIP has its own effects on appetite, fat storage, and insulin response. This dual action is why tirzepatide has generally produced larger average weight loss in clinical trials — though individual results vary widely regardless of which drug is used.
Why the side effects make sense
Once you understand the mechanism, the common side effects become predictable:
- Nausea is largely a consequence of slowed gastric emptying. Food sits in your stomach longer than your body expects, especially after a large or fatty meal.
- Reduced appetite is the intended central effect — but it can overshoot, making it easy to undereat significantly.
- Constipation follows from slowed movement throughout the digestive tract, not just the stomach.
- Fatigue is often downstream of eating too little, not a direct drug effect.
Most of these are dose-dependent and front-loaded — worst during the initial titration weeks, and manageable with the right habits.
What GLP-1 medications do not do
They are not a metabolic reset. They do not permanently change your appetite set-point. They work while you take them and, for most people, their effects diminish after stopping. They also don't distinguish between fat and muscle when producing weight loss — which is why protein intake and resistance training matter so much alongside the medication.
Understanding the mechanism helps set realistic expectations: these are powerful pharmacological tools that change the hormonal environment around eating. They make the work of eating less and losing weight significantly easier — but they shift the difficulty rather than eliminate it. For a direct comparison of GLP-1 therapy against conventional dieting, see GLP-1 vs. Traditional Weight Loss.
This article is educational and not medical advice. Whether a GLP-1 medication is appropriate for you is a conversation for you and a licensed clinician.
Scientific References
4 sources- 1
Drucker DJ
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Cell Metabolism · 27(4) · 2018PMID: 29617641
PubMed - 2
Holst JJ
The Physiology of Glucagon-like Peptide 1
Physiological Reviews · 87(4) · 2007PMID: 17928588
PubMed - 3
Müller TD, et al.
Glucagon-like Peptide 1 (GLP-1)
Molecular Metabolism · 30 · 2019PMID: 31767182
PubMed - 4
Nauck MA, Quast DR, Wefers J, Meier JJ
GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes — State-of-the-Art
Molecular Metabolism · 46 · 2021PMID: 33068776
PubMed
References open in a new tab. Content is reviewed against peer-reviewed literature as part of our editorial policy.
About the author
Modern Weight Science Editorial Team
Editorial Team
Evidence-based research and educational content focused on metabolism, appetite regulation, and sustainable weight management. Our team synthesizes peer-reviewed research into clear, accessible guidance for informed health decisions.
Content reviewed against peer-reviewed research. Read our editorial policy →
Last updated May 2026
Frequently Asked Questions
What is GLP-1 and how does it work?
GLP-1 (glucagon-like peptide-1) is a hormone released by intestinal L-cells after eating. It stimulates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and activates hypothalamic satiety pathways to reduce appetite. GLP-1 receptor agonist medications mimic these effects with a much longer duration — typically one week per injection.
How do GLP-1 medications cause weight loss?
GLP-1 receptor agonists reduce appetite through two pathways: peripheral (slowing gastric emptying extends fullness) and central (activating hypothalamic and brainstem receptors reduces hunger signaling and 'food noise'). The result is a sustained reduction in calorie intake without requiring active willpower against elevated hunger hormones.
What is the difference between semaglutide and tirzepatide?
Semaglutide (Ozempic, Wegovy) activates GLP-1 receptors only. Tirzepatide (Mounjaro, Zepbound) is a dual GLP-1/GIP agonist. Clinical trials show tirzepatide produces higher average weight loss (~20-22% in SURMOUNT-1 vs. ~15% for semaglutide in STEP 1), though individual response varies considerably depending on biology, dose, and adherence.
Are GLP-1 medications safe to use long-term?
The longest available randomized trial data (STEP 5 for semaglutide) shows maintained efficacy and tolerability over two years. Side effects are primarily gastrointestinal and concentrated during dose escalation. As with any prescription medication, long-term risks and benefits must be evaluated with a licensed clinician who knows your individual medical history.
Not medical advice. This guide is for general education only. GLP-1 medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.
Explore Modern GLP-1 Approaches
Telehealth platforms that connect patients with licensed clinicians to evaluate GLP-1 based care.
Ro Body
Licensed physicians review your medical history, discuss GLP-1 receptor agonist options, and provide ongoing monitoring — all remotely.
Explore approachHims & Hers
Connects patients with licensed clinicians who specialize in metabolic care, including evaluation for GLP-1 medications where appropriate.
Explore approachPlushCare
Board-certified physicians available for metabolic health consultations, with the ability to prescribe and monitor evidence-based treatments.
Explore approachAffiliate disclosure: Modern Weight Science may earn a commission if you visit or purchase through these links, at no additional cost to you. Programs are listed for educational relevance. This is not a clinical recommendation — always consult a licensed healthcare professional before starting any treatment.
Weekly Digest
Get Evidence-Based Metabolic Health Insights Weekly
Research-backed insights on metabolism, GLP-1 science, and sustainable weight management — once a week.
Continue reading
Related articles
Ozempic Face: Why It Happens and What Helps
Rapid weight loss produces visible facial changes that have been visible since long before semaglutide — but now they have a brand name attached. The mechanism, the timeline, and what actually mitigates it.
Hair Loss on Semaglutide: Causes, Timeline, and Prevention
Telogen effluvium is the medical name. It's not unique to semaglutide — it follows almost any major caloric deficit or weight loss event. Here's why, when it appears, and what reverses it.
Exercise on GLP-1 Medications: Building a Routine That Works
Lower appetite and slower gastric emptying change how you fuel a workout. Combined with the lean-tissue arithmetic of any large weight loss, exercise priorities reshuffle in ways that aren't obvious from pre-GLP-1 fitness advice.
Setting Realistic Weight Loss Goals on a GLP-1
STEP 1 averaged 14.9% body weight loss at 68 weeks. SURMOUNT-1 averaged 20.9%. Trial averages hide a wide individual range — and the endpoint thinking that surrounds weight goals tends to mislead more than it helps.
